Impurities and contamination in pharmaceutical materials

The presence of contaminants or impurities in pharmaceutical and consumer healthcare products may lead to undesirable pharmacological and/ or toxicological effects, which in turn may affect the safety, efficacy and quality of the product. Contamination and impurity identification and profiling is therefore critical to the safety, efficacy and quality of a pharmaceutical or consumer healthcare product and is a regulatory requirement.

 

Download our fact sheet to find out more about:

  • Discovery/Development
  • Characterisation
  • Safety
  • Quality
  • Equipment

 

LGC Impurities and contamination in pharmaceutical materials

 

 

 

Download

 

 

 

You may also be interested in the following fact sheets:

 

LGC Materials science        LGC Foreign particulate matter        LGC ICH Q3S Elemental impurities testing        LGC Biopharmaceutical residual process impurities        LGC Structural elucidation        LGC Extractables and leachables        LGC Nitrosamine impurities fact sheet